| Trial ID: | L0257 |
| Source ID: | NCT01968759
|
| Associated Drug: |
Sevelamer
|
| Title: |
Sevelamer in Proteinuric CKD
|
| Acronym: |
ANSWER
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease
|
| Interventions: |
DRUG: Sevelamer|DRUG: Ramipril and Irbesartan
|
| Outcome Measures: |
Primary: 24-h urinary protein excretion, Changes from Baseline at 3,4,7 and 8 month. | Secondary: Office blood pressure, At every visit, up to 8 months.|Glomerular Filtration Rate, Changes from baseline at 3,4 and 7 month.
|
| Sponsor/Collaborators: |
Sponsor: Mario Negri Institute for Pharmacological Research
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
53
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2013-10
|
| Completion Date: |
2015-10
|
| Results First Posted: |
|
| Last Update Posted: |
2015-10-12
|
| Locations: |
Clinical Research Center for Rare Diseases, Ranica, Bergamo, 24020, Italy|Azienda Ospedaliera "Bianchi-Melacrino-Morelli" c/o Ospedali Riuniti U.O. Nefrologia, Dialisi e Trapianto, Reggio Calabria, Italy
|
| URL: |
https://clinicaltrials.gov/show/NCT01968759
|
